<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Erythromycin - Medications - Offline Clinical Reference</title>
  <link rel="stylesheet" href="../style.css">
</head>
<body>
  <div class="topbar">
    <div class="topbar-inner">
      <span class="pill"><strong>Erythromycin</strong></span>
      <span class="spacer"></span>
      <div class="nav-btns">
        <a class="btn small" href="../../index.html">Home</a>
        <a class="btn small" href="../../index.html#/sickbay-meds">Back to Medications</a>
      </div>
    </div>
  </div>

  <main class="wrap">
    <section class="section">
      <div class="kicker">Antibiotics / Antivirals</div>
      <h1>Erythromycin</h1>

      <div class="content">
        <h3>Stocked on board</h3>
        <ul>
          <li>Erythromycin 2% Ointment</li>
        </ul>

        <div class="rule"></div>

        <h3>Adult dosing</h3>
        <ul>
          <li><strong>Bacterial conjunctivitis (superficial ocular infections)</strong>
            <ul>
              <li>Apply approximately 1 cm ribbon of ointment to the affected eye(s) 2–6 times daily depending on severity</li>
              <li>Typical regimen: apply 2–4 times daily for 5–7 days</li>
            </ul>
          </li>
          <li><strong>Blepharitis (adjunctive treatment)</strong>
            <ul>
              <li>Apply small amount to eyelid margin 1–2 times daily after lid hygiene/warm compresses</li>
              <li>Duration varies; follow clinical response and local guidance</li>
            </ul>
          </li>
          <li><strong>Prophylaxis of ophthalmia neonatorum (newborn eye infection prevention)</strong>
            <ul>
              <li>1 cm ribbon to lower conjunctival sac of each eye within 1 hour of birth (single application)</li>
            </ul>
          </li>
        </ul>

        <div class="rule"></div>

        <h3>Indications</h3>
        <ul>
          <li>Superficial bacterial ocular infections (conjunctivitis, blepharitis)</li>
          <li>Prophylaxis of neonatal conjunctivitis (ophthalmia neonatorum)</li>
          <li>Appropriate for gram-positive organisms and some gram-negative pathogens; limited coverage compared to fluoroquinolone eye drops</li>
        </ul>

        <div class="rule"></div>

        <h3>Contraindications / cautions</h3>
        <ul>
          <li>Hypersensitivity to erythromycin or macrolide antibiotics</li>
          <li>Not for deep ocular infections, corneal ulcers, or penetrating eye injuries (ophthalmology referral required)</li>
          <li>Ointment may cause temporary blurred vision; counsel accordingly</li>
          <li>Contact lens wear: remove lenses before application; avoid wearing during active infection</li>
        </ul>

        <div class="rule"></div>

        <h3>Adverse effects</h3>
        <ul>
          <li>Temporary blurred vision immediately after application</li>
          <li>Minor eye irritation, stinging, burning (uncommon)</li>
          <li>Allergic reactions (rare): itching, redness, swelling</li>
          <li>Overgrowth of non-susceptible organisms with prolonged use</li>
        </ul>

        <div class="rule"></div>

        <h3>Preparation &amp; administration</h3>
        <ul>
          <li>Wash hands thoroughly before and after application</li>
          <li>Tilt head back, pull down lower eyelid to create a small pocket</li>
          <li>Apply approximately 1 cm ribbon of ointment into the lower conjunctival sac (avoid touching tip to eye or eyelid)</li>
          <li>Close eye gently and roll eyeball to distribute ointment</li>
          <li>Wipe away excess with clean tissue</li>
          <li>Replace cap tightly after use; do not share between patients (infection control)</li>
          <li>Counsel: vision may be blurry for several minutes after application; apply at bedtime if possible to minimize functional impact</li>
        </ul>

        <div class="rule"></div>

        <h3>Monitoring</h3>
        <ul>
          <li>Symptom improvement: reduction in redness, discharge, discomfort within 48–72 hours</li>
          <li>If no improvement after 2–3 days or worsening symptoms (increased pain, vision changes, purulent discharge), reassess diagnosis and consider:
            <ul>
              <li>Resistant organism (may need fluoroquinolone drops if available)</li>
              <li>Viral conjunctivitis (no antibiotic needed)</li>
              <li>Serious ocular pathology requiring specialist evaluation</li>
            </ul>
          </li>
          <li>Monitor for local allergic reaction (stop if occurs)</li>
        </ul>

        <div class="rule"></div>

        <h3>At-sea considerations</h3>
        <ul>
          <li>Conjunctivitis is common in close-quarters; implement infection control (hand hygiene, avoid touching eyes, separate towels/linens)</li>
          <li>Differentiate bacterial from viral conjunctivitis:
            <ul>
              <li>Bacterial: purulent discharge, unilateral onset (may spread), responds to antibiotics</li>
              <li>Viral: watery discharge, often bilateral, may have URI symptoms, self-limited (no antibiotics needed)</li>
            </ul>
          </li>
          <li>Ointment formulation preferred over drops in maritime setting (longer contact time, easier storage, less spillage)</li>
          <li>If vision loss, severe pain, corneal opacity, or suspected penetrating injury: urgent ophthalmology consultation and evacuation planning</li>
          <li>Document laterality, discharge character, and treatment response to guide ongoing therapy</li>
        </ul>

        <div class="rule"></div>

        <h3>Online-only references</h3>
        <ul>
          <li>Health Canada product monograph (Erythromycin ophthalmic ointment): <a href="https://pdf.hres.ca/dpd_pm/00055869.PDF" target="_blank" rel="noopener">https://pdf.hres.ca/dpd_pm/00055869.PDF</a></li>
          <li>DynaMed – Bacterial Conjunctivitis overview: <a href="https://www.dynamed.com/condition/bacterial-conjunctivitis" target="_blank" rel="noopener">https://www.dynamed.com/condition/bacterial-conjunctivitis</a></li>
          <li>American Academy of Ophthalmology – Conjunctivitis PPP: <a href="https://www.aao.org/preferred-practice-pattern/conjunctivitis-ppp-2018" target="_blank" rel="noopener">https://www.aao.org/preferred-practice-pattern/conjunctivitis-ppp-2018</a></li>
        </ul>
      </div>

      <p class="foot">
        Verify dosing and indications against current clinical guidelines.
      </p>
    </section>
  </main>
</body>
</html>
